Antisense Therapeutics Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Antisense Therapeutics Limited with three other
companies in this sector in Australia:
Dimerix Ltd
(2019
sales of 18,108.00 Australian Dollars [US$12,293.34 ]
),
Amplia Therapeutics Ltd
(50,474.00 Australian Dollars [US$34,266.29 ]
), and
Ultracharge Ltd
(83,994.00 Australian Dollars [US$57,022.69 ]
).
Sales Analysis.
Sales increased substantially in 2019:
Antisense Therapeutics Limited reported sales of A$66,168.00 (US$44.92 thousand)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 158.9%
versus 2018, when the company's sales were A$25,553.00 .
Despite this increase, sales are still
well
below the level achieved in 2017, when Antisense Therapeutics Limited
reported sales of A$140,169.00 .